Clinical Trial Update: Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial of anecortave acetate sterile suspension (15 mg) for radiation retinopathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Retinopathy

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Eye Injuries | Phase 2 | Status: TERMINATED